"The medicine with the trade name Viagra corresponds to the International Nonproprietary Name (INN) sildenafil, its production is not localized in Russia. In 2022, Viatris informed about the suspension of the supply of Viagra medicine in the dosage form of a tablet," the ministry said.
The ministry added that in order to ensure local production, the government supported a project designed to organize and conduct clinical trials of the drug based on the same component — sildenafil — in the form of pills.
"Currently, the technological possibility of manufacturing medicines with the INN sildenafil on the territory of the Russian Federation at various stages has been ensured," the ministry added.
The volume of production of these medicine in the first three quarters of 2022 increased by more than 11% in physical terms. At the same time, the sales of Viagra in Russia also increased by more than 15%.